By Business/Source
Currency:CHF
2025/FY
Stock NameRevenueRatio
Integrated Biologics3.65B55.95%
Advanced Synthesis1.62B24.76%
Specialized Modalities1.1B16.84%
Corporate/Eliminations160M2.45%
By Country/Region
Currency:CHF
2023/FY
Stock NameRevenueRatio
United States2.14B31.80%
Other1.17B17.40%
Switzerland1.17B17.39%
Japan544M8.10%
Ireland368M5.48%
Belgium341M5.08%
Denmark322M4.79%
Germany302M4.50%
Rest of Europe195M2.90%
China172M2.56%
View all